We reasoned that if this mechano‐signaling is relevant in ARVC, then genes belonging to the RhoA/cytoskeletal pathway may be targets of pathogenic mutations. The gene discussed is RHOA; the disease is Arrhythmogenic right ventricular dysplasia.